Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Dr. Arshad Khanani Joins Ophtea as Chief Medical Advisor
Opthea Limited announced Dr. Arshad M. Khanani, MD, MA, FASRS, as its new Chief Medical Advisor. Dr. Khanani, renowned in retina specialization and clinical research, brings a wealth of expertise from his tenure at Sierra Eye Associates and his academic…
A Guide to Eyelid Hygiene: Preventing Common Eye Conditions
Eyelid hygiene is an essential, yet often overlooked, aspect of overall eye health. Neglecting the cleanliness of your eyelids can lead to various conditions, including swollen eyelids, eyelid twitching, styes, eyelid dermatitis, and bumps on the eyelid. Understanding and practicing…
Evmann Holding Eyes Expansion in Ophthalmology at ESCRS
Evmann Investments Holding BV is taking a proactive approach to strengthening its investment footprint in the ophthalmology sector. The Netherlands-based holding company, with operations spanning over 93 countries via its German subsidiary VSY Biotechnology GmbH, is setting a new course…
What Is Meibomian Gland Dysfunction?
Meibomian gland dysfunction (MGD) is a common eye disorder that affects the meibomian glands, which are located in the eyelids and produce the oily layer of the tear film. The disorder is characterized by the blockage or dysfunction of these…
Study Finds Key Genes Linked to Primary Open-Angle Glaucoma
In a recent study published in Nature Communications, researchers from Mass Eye and Ear, led by Ayellet Segrè, Ph.D., alongside Janey Wiggs, MD, Ph.D., conducted an extensive investigation that merged findings from a large cross-ancestry genome-wide association study meta-analysis of…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product has received the green light from the United States Food and Drug Administration (U.S. FDA), marking a crucial milestone for the company’s expansion in the American pharmaceutical market.…
ESCRS Winter Meeting Starts with Dynamic Program
The European Society of Cataract and Refractive Surgeons (ESCRS) has commenced its highly anticipated Winter Meeting in Frankfurt, Germany. The event, which runs from February 15th to 18th, 2024, promises to be a hub of innovation and knowledge exchange in…
Opthea Completes Enrollment for Wet AMD Trial
Opthea has reached a significant milestone in its quest to combat wet age-related macular degeneration (AMD) with the completion of patient enrollment in the COAST phase 3 pivotal clinical trial. The trial investigates sozinibercept (OPT-302), a promising vascular endothelial growth…
VSY Biotechnology’s 100% Glistening-Free IOL Material
VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material. In a statement, Andreas Kühnel, the Managing Director at VSY Biotechnology GmbH, expressed his excitement about the groundbreaking innovation, saying, “This innovative solution, developed…
A Novel Approach To Trifocal IOLs
AcrivaUD Trinova is the world’s first and only sinusoidal trifocal IOL manufactured with Sinusoidal Vision Technology (SVT). Its sinusoidal optic design eliminates the sharp steps (diffractive rings) found with traditional trifocal IOLs. The smoothly varying surface profile derived from the…